Tumor suppression in basal keratinocytes via dual non-cell-autonomous functions of a Na,K-ATPase beta subunit

  1. Julia Hatzold
  2. Filippo Beleggia
  3. Hannah Herzig
  4. Janine Altmüller
  5. Peter Nürnberg
  6. Wilhelm Bloch
  7. Bernd Wollnik
  8. Matthias Hammerschmidt  Is a corresponding author
  1. University of Cologne, Germany
  2. German Sport University Cologne, Germany
  3. University Hospital Cologne, Germany

Abstract

Molecular pathways underlying tumor suppression are incompletely understood. Here, we identify cooperative non-cell-autonomous functions of one and the same gene as a novel mechanism of tumor suppression in basal keratinocytes of zebrafish embryos. A loss-of-function mutation in atp1b1a, encoding the beta subunit of a Na,K-ATPase pump, causes edema and epidermal malignancy. Strikingly, basal cell carcinogenesis only occurs when Atp1b1a function is compromised in both the overlying periderm (resulting in compromised epithelial polarity and adhesiveness) and in kidney and heart (resulting in hypotonic stress). Blockade of the ensuing PI3K-AKT-mTORC1-NFκB-MMP9 pathway activation in basal cells, as well as systemic isotonicity, prevents malignant transformation. Our results identify hypotonic stress as a thus far unrecognized contributor to tumor development and establish a novel paradigm of tumor suppression.

Article and author information

Author details

  1. Julia Hatzold

    Institute for Zoology, Developmental Biology Unit, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Filippo Beleggia

    Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Hannah Herzig

    Institute of Cardiology and Sports Medicine, German Sport University Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Janine Altmüller

    Institute of Human Genetics, University Hospital Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Peter Nürnberg

    Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Wilhelm Bloch

    Institute of Cardiology and Sports Medicine, German Sport University Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Bernd Wollnik

    Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Matthias Hammerschmidt

    Institute for Zoology, Developmental Biology Unit, University of Cologne, Cologne, Germany
    For correspondence
    mhammers@uni-koeln.de
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: All zebrafish experiments were approved by the national animal care committees (LANUV Nordrhein-Westfalen; 8.87-50.10.31.08.129; 84-02.04.2012.A251; City of Cologne; 576.1.36.6.3.01.10 Be) and the University of Cologne.

Copyright

© 2016, Hatzold et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,763
    views
  • 576
    downloads
  • 22
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Julia Hatzold
  2. Filippo Beleggia
  3. Hannah Herzig
  4. Janine Altmüller
  5. Peter Nürnberg
  6. Wilhelm Bloch
  7. Bernd Wollnik
  8. Matthias Hammerschmidt
(2016)
Tumor suppression in basal keratinocytes via dual non-cell-autonomous functions of a Na,K-ATPase beta subunit
eLife 5:e14277.
https://doi.org/10.7554/eLife.14277

Share this article

https://doi.org/10.7554/eLife.14277

Further reading

    1. Cancer Biology
    2. Evolutionary Biology
    Arman Angaji, Michel Owusu ... Johannes Berg
    Research Article

    In growing cell populations such as tumours, mutations can serve as markers that allow tracking the past evolution from current samples. The genomic analyses of bulk samples and samples from multiple regions have shed light on the evolutionary forces acting on tumours. However, little is known empirically on the spatio-temporal dynamics of tumour evolution. Here, we leverage published data from resected hepatocellular carcinomas, each with several hundred samples taken in two and three dimensions. Using spatial metrics of evolution, we find that tumour cells grow predominantly uniformly within the tumour volume instead of at the surface. We determine how mutations and cells are dispersed throughout the tumour and how cell death contributes to the overall tumour growth. Our methods shed light on the early evolution of tumours in vivo and can be applied to high-resolution data in the emerging field of spatial biology.

    1. Cancer Biology
    2. Evolutionary Biology
    Susanne Tilk, Judith Frydman ... Dmitri A Petrov
    Research Article

    In asexual populations that don’t undergo recombination, such as cancer, deleterious mutations are expected to accrue readily due to genome-wide linkage between mutations. Despite this mutational load of often thousands of deleterious mutations, many tumors thrive. How tumors survive the damaging consequences of this mutational load is not well understood. Here, we investigate the functional consequences of mutational load in 10,295 human tumors by quantifying their phenotypic response through changes in gene expression. Using a generalized linear mixed model (GLMM), we find that high mutational load tumors up-regulate proteostasis machinery related to the mitigation and prevention of protein misfolding. We replicate these expression responses in cancer cell lines and show that the viability in high mutational load cancer cells is strongly dependent on complexes that degrade and refold proteins. This indicates that the upregulation of proteostasis machinery is causally important for high mutational burden tumors and uncovers new therapeutic vulnerabilities.